Edition:
United States

Sucampo Pharmaceuticals Inc (SCMP.OQ)

SCMP.OQ on NASDAQ Stock Exchange Global Market

16.00USD
8 Dec 2017
Change (% chg)

$0.40 (+2.56%)
Prev Close
$15.60
Open
$15.70
Day's High
$16.80
Day's Low
$15.40
Volume
632,445
Avg. Vol
159,096
52-wk High
$17.70
52-wk Low
$9.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 61.27 0.159
Jun '17 59.90 -3.922
Mar '17 56.28 0.100
FY 2016 Dec '16 73.02 0.340
Sep '16 57.87 0.186
Jun '16 51.95 -0.019
Mar '16 47.21 -0.095
FY 2015 Dec '15 55.37 0.226
Sep '15 33.45 0.156
Jun '15 34.88 0.207
Mar '15 29.48 0.140
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 7 75.16 77.70 72.50 61.81
Quarter Ending Mar-18 2 58.82 62.40 55.24 --
Year Ending Dec-17 7 252.55 255.10 250.00 227.38
Year Ending Dec-18 7 251.80 273.89 201.50 244.56
Earnings (per share)
Quarter Ending Dec-17 6 0.35 0.38 0.32 0.56
Quarter Ending Mar-18 2 0.31 0.36 0.26 --
Year Ending Dec-17 5 1.13 1.16 1.09 1.68
Year Ending Dec-18 6 1.27 1.90 1.05 1.83
LT Growth Rate (%) 1 3.00 3.00 3.00 11.75
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 186.11 35.51
P/E High - Last 5 Yrs. 57.01 274.30 45.27
P/E Low - Last 5 Yrs. 23.67 92.17 24.24
Beta 1.40 0.83 0.91
Price to Sales (TTM) 2.98 113.99 5.83
Price to Book (MRQ) 18.74 21.50 5.68
Price to Tangible Book (MRQ) -- 25.23 7.26
Price to Cash Flow (TTM) -- 101.64 24.44
% Owned Institutions 66.98 5.68 1.39

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.96 5.23
Payout Ratio(TTM) -- 95.86 45.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 5.86 -2.88 6.82
Sales (TTM) vs TTM 1 Yr. Ago 17.92 30.21 5.65
Sales - 5 Yr. Growth Rate 33.25 33.15 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -14.48 -147.47 7.23
EPS (TTM) vs TTM 1 Yr. Ago -1,216.87 -- --
EPS - 5 Yr. Growth Rate -- 43.45 10.90
Capital Spending - 5 Yr. Growth Rate -17.89 40.96 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.46 1.79 2.54
Current Ratio (MRQ) 5.11 5.75 3.56
LT Debt to Equity (MRQ) 736.60 14.45 13.23
Total Debt to Equity (MRQ) 736.60 16.90 19.24
Interest Coverage (TTM) 1.72 -147.16 44.55

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 72.82 43.05 54.80
Gross Margin - 5 Yr. Avg. 78.44 55.37 52.40
EBITD Margin (TTM) -31.59 -- --
EBITD - 5 Yr. Avg 32.69 -219.17 15.52
Operating Margin (TTM) -49.64 -631.99 6.76
Operating Margin - 5 Yr. Avg. 19.27 -236.03 11.03
Pre-Tax Margin (TTM) -58.53 -602.68 7.58
Pre-Tax Margin - 5 Yr. Avg. 15.54 -236.35 11.44
Net Profit Margin (TTM) -60.24 -600.25 3.81
Net Profit Margin - 5 Yr. Avg. 11.51 -239.62 7.73
Effective Tax Rate (TTM) -- 15.32 24.25
Effective Tax Rate - 5 Yr. Avg. 25.98 18.76 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,801,935 21,633,432 858,823,705
Net Income/Employee (TTM) -1,085,561 -1,703,997 100,224,560
Receivable Turnover (TTM) 9.31 25.40 6.12
Inventory Turnover (TTM) 2.81 2.62 3.55
Asset Turnover (TTM) 0.59 0.42 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -35.60 -9.13 11.35
Return on Assets - 5 Yr. Avg. 6.41 0.30 12.32
Return on Investment (TTM) -40.58 -11.32 14.47
Return on Investment - 5 Yr. Avg. 8.04 3.50 16.13
Return on Equity (TTM) -163.62 -35.69 16.06
Return on Equity - 5 Yr. Avg. 20.63 5.92 17.32
  1 Year 3 Year 5 Year
Sales % 50.19 36.94 33.25
EPS (TTM) % -42.16 36.85 --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Sucampo Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 66.95%
# of Holders: 240
Total Shares Held: 31,221,766
3 Mo. Net Change: 4,564,803
# New Positions: 31
# Closed Positions: 20
# Increased Positions: 111
# Reduced Positions: 79
# Net Buyers: 32
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.